Market capitalization | $97.33m |
Enterprise Value | $94.92m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 1.94 |
P/S ratio (TTM) P/S ratio | 1.99 |
P/B ratio (TTM) P/B ratio | 4.28 |
Revenue growth (TTM) Revenue growth | 21.29% |
Revenue (TTM) Revenue | $48.87m |
As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.
2 Analysts have issued a LENSAR Inc forecast:
2 Analysts have issued a LENSAR Inc forecast:
Sep '24 |
+/-
%
|
||
Revenue | 49 49 |
21%
21%
|
|
Gross Profit | 23 23 |
7%
7%
|
|
EBITDA | -4.86 -4.86 |
40%
40%
|
EBIT (Operating Income) EBIT | -8.61 -8.61 |
28%
28%
|
Net Profit | -17 -17 |
28%
28%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
LENSAR, Inc. engages in the development of femtosecond laser technology for refractive cataract surgery. Its product offers automation and customization options for astigmatism treatment planning and other steps of the refractive cataract surgery procedure. The company was founded by Scott Addyman, Randy W. Frey, and Ronald R. Krueger in 2004 and is headquartered in Orlando, FL.
Head office | United States |
CEO | Nicholas Curtis |
Employees | 130 |
Founded | 2004 |
Website | www.lensar.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.